Xiaolu Yang
- Cancer Research top 0.5%
- Molecular Biology top 0.5%
- Cell death mechanisms and regulation 28
- Ubiquitin and proteasome pathways 24
- Mitochondrial Function and Pathology 7
- Immunology top 1%
- interferon and immune responses 12
- Immune Cell Function and Interaction 8
- Aging top 2%
- Oncology top 2%
- Cancer-related Molecular Pathways 10
-
- Endoplasmic Reticulum Stress and Disease 13
-
- Autophagy in Disease and Therapy 10
- Co-authors
- Howard Y. ChangDavid BaltimoreMarian CarlsonPeng JiangWenjing DuShimin HuAnthony MancusoRoya Khosravi‐Far
- Partner nations
- United StatesChinaRussia
In The Last Decade
Xiaolu Yang
86 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Cancer Research 2.2k
- Molecular Biology 6.7k
- Immunology 2.0k
- Aging 118
- Oncology 1.6k
Countries citing papers authored by Xiaolu Yang
This map shows the geographic impact of Xiaolu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolu Yang more than expected).
Fields of papers citing papers by Xiaolu Yang
This network shows the impact of papers produced by Xiaolu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolu Yang. The network helps show where Xiaolu Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaolu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2020 | 67 | |
| 5 | 2020 | 48 | |
| 6 | 2019 | 25 | |
| 7 | 2018 | 54 | |
| 8 | 2016 | 3 | |
| 9 | 2012 | 91 | |
| 10 | p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenasebreakdown → | 2011 | 619 |
| 11 | 2010 | 155 | |
| 12 | 2008 | 53 | |
| 13 | 2008 | 320 | |
| 14 | 2006 | 18 | |
| 15 | 2006 | 6 | |
| 16 | 2006 | 197 | |
| 17 | 2005 | 1 | |
| 18 | 2005 | 35 | |
| 19 | 2003 | 57 | |
| 20 | Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosisbreakdown → | 1997 | 737 |
About Xiaolu Yang
Xiaolu Yang is a scholar working on Immunology, Cancer Research and Molecular Biology, having authored 89 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (28 papers), Ubiquitin and proteasome pathways (24 papers), Endoplasmic Reticulum Stress and Disease (13 papers), interferon and immune responses (12 papers), Cancer-related Molecular Pathways (10 papers), Autophagy in Disease and Therapy (10 papers), Immune Cell Function and Interaction (8 papers) and Mitochondrial Function and Pathology (7 papers). The work is most often cited by research in Cancer Research (2.2k citations), Molecular Biology (6.7k citations) and Immunology (2.0k citations). Xiaolu Yang has collaborated with scholars based in United States, China and Russia. Frequent co-authors include Howard Y. Chang, David Baltimore, Marian Carlson, Peng Jiang, Wenjing Du, Shimin Hu, Anthony Mancuso, Roya Khosravi‐Far, Mian Wu and Hidenori Ichijo. Their work appears in journals such as Journal of Biological Chemistry, Science, Cell Cycle, Nature Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.